Zedilarf

Zedilarf (Dapagliflozin) is an oral medication used to manage blood sugar levels in adults with type 2 diabetes. It belongs to the SGLT2 inhibitor class, helping reduce glucose reabsorption in the kidneys. This product is manufactured by Pharmapath Sa and sourced from the EU.

Dapagliflozin is prescribed to improve glycemic control in adults with type 2 diabetes when diet and exercise alone are insufficient. It may also be used alongside other diabetes medications under medical supervision. The drug works by helping the kidneys remove glucose through urine, lowering blood sugar levels naturally.

Users of dapagliflozin may experience increased urination as the body removes excess glucose. Some individuals report mild thirst or fatigue during the initial adjustment period. These effects are generally temporary and vary by person.

Store dapagliflozin at room temperature away from moisture and heat. Keep it out of reach of children and pets. If you experience signs of dehydration or low blood pressure, consult a healthcare provider promptly.

Dapagliflozin may interact with diuretics or blood pressure medications, potentially increasing dehydration risk. Alcohol use can amplify these effects. Always inform your doctor about all medications, including over-the-counter products, before starting dapagliflozin.